News Focus
News Focus
Followers 80
Posts 24870
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Monday, 06/06/2022 6:58:08 AM

Monday, June 06, 2022 6:58:08 AM

Post# of 27845
CRIS - .94 Pre-market 1.15/1.16

Curis Announced TakeAim Lymphoma Data Presented at ASCO for the Combination of Emavusertib Plus Ibrutinib Show Tumor Reduction in 8 of 9 Evaluable Patients, Including 2 Complete Responses and 2 Partial Responses

https://stockcharts.com/h-sc/ui?s=cris

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today